Andrea Gelemanović, Ph.D., is a molecular and computational biologist with a doctoral degree in genetic epidemiology obtained at the University of Split School of Medicine in Split, Croatia (2019). She is currently employed as a postdoctoral researcher at the Mediterranean Institute for Life Sciences in Split, Croatia. She was involved in several projects as a bioinformatics analyst of various -omics data, most notably the EU FP7 “PREPARE - Platform foR European Preparedness Against (Re-)emerging Epidemics” (School of Medicine, University of Split, Croatia) and EU FP7 ERA Chair “VetMedZg - Upgrading the research performance in molecular medicine at the Faculty of Veterinary Medicine University of Zagreb” (Faculty of Veterinary Medicine, University of Zagreb, Croatia). During her PhD, her main research focus was the impact of human genetic polymorphisms on the susceptibility to various infectious diseases, while she is currently working on a project to understand the importance of cell-to-cell communication in cancer metastasis. She was awarded a British Scholarship Trust for a short-term research visit to the MRC Institute of Genetics and Molecular Medicine in Edinburgh, UK, and was a winner candidate of the 2016 New Voices in Global Health initiative held at the World Health Summit in Berlin, Germany. She was also involved in various projects for science popularization, of which the most notable is the science communication competition FameLab where she was a winner at the national level (Zagreb, Croatia, 2013) and a runner-up at the international level (Cheltenham, UK, 2013).